Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Twist Bioscience Officer Cho Files to Sell 949 Shares

Dennis Cho, an officer of Twist Bioscience Corp, filed a Form 144 notice on November 3, 2026, proposing the sale of 949 shares of common stock on NASDAQ with an aggregate market value of $128,496.21.

Vinay Lochav | 03 November 2026

Fate Therapeutics Officer Adawi Files to Sell 6,582 Shares

Kamal Adawi, an officer of Fate Therapeutics Inc, filed a Form 144 notice on November 3, 2026, proposing the sale of 6,582 shares of common stock through Fidelity Brokerage Services LLC on NASDAQ.

Manish Choudhary | 03 November 2026

Wooldridge Acquires 406 UFP Industries Shares at $83.14

Director Michael G. Wooldridge filed a Form 4 with the SEC on November 3, 2026, disclosing the acquisition of 406 shares of UFP Industries Inc common stock on November 2, 2026.

Nitish Kishor | 03 November 2026

Dream Finders Homes Q3 2026: Revenue Dips, Preferred Stock Reissued

Dream Finders Homes, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 3, 2026, covering the fiscal quarter ended September 30, 2026.

Nitish Kishor | 03 November 2026

Citigroup 35-Month Callable Coupon Notes Linked to NDX, RTY, KRE

Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., filed a free writing prospectus on November 3, 2026, disclosing preliminary terms for 35-month callable contingent coupon securities linked to the worst of three underlyings: the Nasdaq-100 Index, the Russell 2000 Index, and the SPDR …

Shwetambri Chauhan | 03 November 2026

Leproust Files Form 144 to Sell 4,573 Twist Bioscience Shares

Emily M. Leproust, an officer and director of Twist Bioscience Corp, filed a Form 144 notice on November 3, 2026, disclosing a proposed sale of 4,573 shares of Twist Bioscience common stock on NASDAQ with an aggregate market value of $619,191.97.

Aakashdeep | 03 November 2026

Paula Green Files Form 144 to Sell 1,007 Twist Bioscience Shares

Twist Bioscience Corp officer Paula Green filed a Form 144 notice of proposed sale on November 3, 2026, covering 1,007 shares of common stock acquired through a restricted stock vesting on November 2, 2026.

Manish Choudhary | 03 November 2026

Murphy USA Director Robert Murphy Files Form 144 for 2,000 Shares

Murphy USA, Inc. director Robert Madison Murphy filed a Form 144 notice of proposed sale on November 3, 2026, covering 2,000 shares of common stock held through the Anna Elizabeth Murphy Irrevocable Trust.

Manish Choudhary | 03 November 2026

Lear Corp Officer Cardew Plans 5,000-Share Rule 144 Sale

Lear Corporation officer Jason M. Cardew filed a Form 144 notice of proposed sale on November 3, 2026, disclosing plans to sell 5,000 shares of Lear common stock on NYSE through Fidelity Brokerage Services LLC.

Vinay Lochav | 03 November 2026

JPMorgan IBIT Auto Callable Barrier Notes Due Nov 2029

JPMorgan Chase Financial Company LLC filed a free writing prospectus on November 3, 2026, disclosing terms for Auto Callable Accelerated Barrier Notes linked to the iShares Bitcoin Trust ETF, with a pricing date of November 24, 2026, and a maturity date of November 29, …

Nitish Kishor | 03 November 2026
Support

Hi! How can we help you today?

Loading…